🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/11/2009 | 31,37 | 31,96 | 31,20 | 31,90 | +2,58% | 2,40% | 30.584.098 |
| 06/11/2009 | 31,12 | 31,44 | 30,74 | 31,10 | -0,37% | 2,24% | 20.797.141 |
| 05/11/2009 | 31,00 | 31,90 | 31,00 | 31,21 | +0,21% | 2,89% | 23.830.786 |
| 04/11/2009 | 29,90 | 31,35 | 29,82 | 31,15 | +6,42% | 5,11% | 37.948.290 |
| 03/11/2009 | 29,67 | 29,85 | 28,90 | 29,27 | -1,89% | 3,18% | 71.181.522 |
| 02/11/2009 | 29,69 | 30,06 | 29,54 | 29,83 | +1,07% | 1,74% | 22.417.244 |
| 30/10/2009 | 29,74 | 30,32 | 29,42 | 29,51 | -1,21% | 3,05% | 42.406.377 |
| 29/10/2009 | 30,56 | 30,56 | 29,48 | 29,88 | -2,31% | 3,53% | 42.898.518 |
| 28/10/2009 | 31,10 | 31,20 | 30,53 | 30,58 | -1,17% | 2,15% | 15.802.268 |
| 27/10/2009 | 31,10 | 31,39 | 30,70 | 30,94 | +1,28% | 2,24% | 19.670.541 |
| 26/10/2009 | 31,01 | 31,53 | 30,41 | 30,55 | -1,26% | 3,60% | 19.226.084 |
| 23/10/2009 | 31,26 | 31,44 | 30,71 | 30,94 | -1,34% | 2,35% | 17.948.153 |
| 22/10/2009 | 30,91 | 31,40 | 29,83 | 31,36 | +0,58% | 5,09% | 25.450.575 |
| 21/10/2009 | 32,20 | 32,25 | 31,12 | 31,18 | -3,08% | 3,53% | 25.395.241 |
| 20/10/2009 | 32,36 | 32,61 | 32,09 | 32,18 | -0,03% | 1,62% | 24.308.989 |
| 19/10/2009 | 31,59 | 32,28 | 31,59 | 32,19 | +1,57% | 2,17% | 29.333.310 |
| 16/10/2009 | 31,75 | 31,85 | 31,44 | 31,69 | -0,27% | 1,29% | 21.300.914 |
| 15/10/2009 | 31,32 | 31,87 | 31,13 | 31,77 | +1,22% | 2,38% | 23.478.973 |
| 14/10/2009 | 31,24 | 31,50 | 30,84 | 31,39 | +1,48% | 2,11% | 38.314.042 |
| 13/10/2009 | 31,24 | 31,44 | 30,87 | 30,94 | -1,34% | 1,83% | 21.154.404 |
| 12/10/2009 | 31,22 | 31,48 | 31,01 | 31,36 | +0,92% | 1,50% | 11.445.208 |
| 09/10/2009 | 30,97 | 31,18 | 30,85 | 31,07 | +0,40% | 1,08% | 11.900.354 |
| 08/10/2009 | 30,91 | 31,06 | 30,75 | 30,94 | +0,75% | 0,99% | 11.952.545 |
| 07/10/2009 | 30,91 | 30,99 | 30,48 | 30,72 | -0,98% | 1,67% | 12.144.329 |
| 06/10/2009 | 30,48 | 31,07 | 30,22 | 31,02 | +2,33% | 2,79% | 21.649.794 |
| 05/10/2009 | 29,98 | 30,34 | 29,75 | 30,31 | +0,38% | 1,97% | 18.305.730 |
| 02/10/2009 | 29,75 | 30,37 | 29,67 | 30,20 | +1,51% | 2,37% | 21.461.154 |
| 01/10/2009 | 30,29 | 30,34 | 29,61 | 29,75 | -1,42% | 2,43% | 17.994.894 |
| 30/09/2009 | 30,51 | 30,52 | 29,72 | 30,18 | -0,69% | 2,63% | 21.388.946 |
| 29/09/2009 | 30,55 | 30,74 | 30,23 | 30,39 | -0,56% | 1,69% | 14.767.997 |